Dr Sushil Shah, Chairman and Founder, Metropolis Healthcare Awarded With Maharashtra Gaurav Award 2017

IMT News Desk
IMT News Desk
· 2 min read
Dr. Sushil Shah, Chairman and Founder, Metropolis Healthcare Ltd

Dr Sushil Shah, Chairman and Founder, Metropolis Healthcare Ltd., was awarded the prestigious Maharashtra Gaurav Award for his significant contribution to the pathology industry. The award was bestowed by Mr. Ram Kadam, Member of Assembly and Mr. Kirit Somaiya, Member of Parliament at a function held in Ghatkopar.

On winning the award, Dr. Shah said, “It is an honour to receive The Maharashtra Gaurav Award. This award is a testimony for the hard work we put in at Metropolis Healthcare. I would like to thank my entire team for their dedication and continuous support towards making our vision comes true.”

A champion of turnarounds in the Indian Pathology Industry: Dr. Shah was honored for his distinguished services to the state and for his outstanding individual achievements. The company’s DNA for quality comes from Dr. Shah’s acute focus on quality lab processes and customer care. Dr Sushil Shah is credited with building the first referral laboratory in Mumbai. A visionary, he is single handedly responsible for bringing in various technologies in to the nation; some of which are Radio Immunoassays, Flow Cytometry, HIV & HCV Viral Load Testing, Digital Pathology, Nephelometry, Transcripted Mediated Amplification, High Performance Liquid Chromatography amongst others. In addition, Metropolis was the first lab in all of Maharashtra to receive the CAP (College of American Pathologists) accreditation, which is a global gold standard in lab accreditations.

Today, Metropolis is a leading healthcare brand, catering to over 200,000 doctors, laboratories and hospitals, processing more than 30 million tests annually.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk